Novartis just handed out a $8.7 billion endorsement for new therapies that are changing how we treat genetic diseases – mySanAntonio.com
mySanAntonio.com |
Novartis just handed out a $8.7 billion endorsement for new therapies that are changing how we treat genetic diseases
mySanAntonio.com It's been a big couple of years for gene therapies. In December 2017, the FDA approved the first gene therapy, made by Spark Therapeutics, which is used to treat a hereditary form of blindness. Earlier in the year, the FDA approved the first cell … |
